GleamWall
中文EN

MRNA Moderna, Inc.

Biological Products, (No Diagnostic Substances) · Nasdaq · SEC CIK 1682852 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY13.1%
TTM net income YoY10.5%
TTM EPS YoY12.7%
Revenue 3-yr CAGR-34.8%
Net income 3-yr CAGR—

Margins

Gross margin28.0%
Operating margin-116.0%
Net margin-110.5%
FCF margin-78.0%
EBITDA margin-106.6%

Returns

ROE-34.5%
ROA-21.8%
ROIC (approx.)-33.4%
Asset turnover0.20x

Leverage & solvency

Liabilities / assets49.2%
Debt / equity0.00x
Current ratio3.62x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.64x
Accruals ratio-7.8%
Payout ratio—
Capex / revenue7.3%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$1.94B$3.24B
Cost of revenue$868.00M$1.46B
Gross profit$1.08B$1.77B
R&D expense$3.13B$4.54B
SG&A expense$1.02B$1.17B
Operating income-$3.07B-$3.94B
Pretax income-$2.77B-$3.61B
Income tax$54.00M-$46.00M
Net income-$2.82B-$3.56B
EBITDA-$2.86B-$3.76B
EPS (basic)-7.26-9.28
EPS (diluted)-7.26-9.28
Weighted avg. shares (diluted)389.00M384.00M
Balance sheet
Cash & equivalents$2.60B$1.93B
Short-term investments$3.20B$5.10B
Receivables$184.00M$358.00M
Inventory$153.00M$117.00M
Current assets$6.54B$8.10B
PP&E, net$2.13B$2.20B
Goodwill$52.00M$52.00M
Intangibles$45.00M$40.00M
Total assets$12.34B$14.14B
Current liabilities$1.99B$2.21B
Long-term debt$590.00M$0
Total debt$590.00M$0
Total liabilities$3.69B$3.24B
Shareholders' equity$8.65B$10.90B
Net debt-$2.00B-$1.93B
Shares outstanding394.00M386.00M
Cash flow statement
Operating cash flow-$1.87B-$3.00B
Capital expenditure$192.00M$1.05B
Free cash flow-$2.06B-$4.05B
Investing cash flow$1.95B$1.95B
Financing cash flow$593.00M$56.00M
Depreciation & amortization$211.00M$185.00M
Stock-based compensation$483.00M$429.00M
Share buybacks$2.00M$0

Free plan shows the latest 2 periods; Pro shows all 10 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.